Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Jul 2023
Historique:
received: 21 05 2023
revised: 22 06 2023
accepted: 27 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Melanocortins play crucial roles in regulating the stress response, inflammation, and skin pigmentation. In this review, we focus on the melanocortin 1 receptor (MC1R), a G protein-coupled receptor primarily known for regulating skin pigmentation and exhibiting anti-inflammatory effects. First, we provide an overview of the structure, signaling pathways, and related diseases of MC1R. Next, we discuss the potential therapeutic use of synthetic peptides and small molecule modulators of MC1R, highlighting the development of various drugs that enhance stability through amino acid sequence modifications and small molecule drugs to overcome limitations associated with peptide characteristics. Notably, MC1R-targeted drugs have applications beyond skin pigmentation-related diseases, which predominantly affect MC1R in melanocytes. These drugs can also be useful in treating inflammatory diseases with MC1R expression present in various cells. Our review underscores the potential of MC1R-targeted drugs to treat a wide range of diseases and encourages further research in this area.

Identifiants

pubmed: 37569558
pii: ijms241512152
doi: 10.3390/ijms241512152
pmc: PMC10418475
pii:
doi:

Substances chimiques

Peptides 0
Receptor, Melanocortin, Type 1 0
MC1R protein, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Foundation of Korea
ID : NRF-2020R1A6A1A03043708 and NRF-2021R1A2C1012280

Références

Science. 2002 May 31;296(5573):1636-9
pubmed: 12040175
In Vitro Cell Dev Biol Anim. 2002 Jan;38(1):54-7
pubmed: 11963970
Biochim Biophys Acta. 1996 Aug 28;1313(2):130-8
pubmed: 8781560
Oncogene. 2018 Jul;37(27):3631-3646
pubmed: 29622793
J Leukoc Biol. 2000 Feb;67(2):233-9
pubmed: 10670585
Biochem Biophys Res Commun. 1996 Feb 15;219(2):521-5
pubmed: 8605020
J Hematol Oncol. 2012 Jan 24;5:1
pubmed: 22272800
J Dermatol Sci. 2011 Jul;63(1):23-32
pubmed: 21602033
Biochemistry (Mosc). 2013 Nov;78(11):1228-37
pubmed: 24460937
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5754-8
pubmed: 6777774
J Immunol. 1998 Sep 15;161(6):2873-80
pubmed: 9743348
J Leukoc Biol. 1998 Jun;63(6):740-5
pubmed: 9620667
J Med Chem. 1987 Nov;30(11):2126-30
pubmed: 2822931
J Med Chem. 1989 Dec;32(12):2555-61
pubmed: 2555512
Exp Eye Res. 2006 Dec;83(6):1366-72
pubmed: 16965771
Biochem J. 1998 Apr 1;331 ( Pt 1):211-6
pubmed: 9512481
Ann N Y Acad Sci. 1999 Oct 20;885:277-86
pubmed: 10816661
Arthritis Res Ther. 2022 Sep 1;24(1):210
pubmed: 36050717
Genomics. 1994 Jan 15;19(2):394-5
pubmed: 8188275
Cell Mol Life Sci. 2011 Dec;68(23):3823-41
pubmed: 21744067
Cancer Res. 1994 May 15;54(10):2604-10
pubmed: 8168086
Front Genet. 2016 May 31;7:95
pubmed: 27303435
Genes Dev. 1998 Feb 1;12(3):316-30
pubmed: 9450927
Endocrinology. 2009 Jul;150(7):3197-206
pubmed: 19282378
Eur J Pharmacol. 2020 Aug 5;880:173186
pubmed: 32416182
Brain Res Dev Brain Res. 1995 Feb 16;84(2):245-52
pubmed: 7743644
PLoS One. 2014 Apr 02;9(4):e93433
pubmed: 24695675
PLoS One. 2013 Aug 05;8(8):e71056
pubmed: 23940690
Science. 1992 Aug 28;257(5074):1248-51
pubmed: 1325670
Br J Cancer. 2002 Aug 12;87(4):414-22
pubmed: 12177778
Ann N Y Acad Sci. 1999 Oct 20;885:188-95
pubmed: 10816652
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Nat Rev Cancer. 2007 Feb;7(2):79-94
pubmed: 17251915
J Cell Sci. 1994 Jan;107 ( Pt 1):205-11
pubmed: 8175909
Ann N Y Acad Sci. 2003 Jun;994:1-11
pubmed: 12851292
Annu Rev Biochem. 1998;67:653-92
pubmed: 9759500
Cancer Res. 1989 Nov 15;49(22):6352-8
pubmed: 2804981
N Engl J Med. 2015 Jul 2;373(1):48-59
pubmed: 26132941
ACS Pharmacol Transl Sci. 2020 Aug 18;3(5):921-930
pubmed: 33073191
J Clin Invest. 1994 May;93(5):2258-62
pubmed: 8182158
Nature. 1957 Jun 29;179(4574):1346-7
pubmed: 13451616
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
PLoS One. 2016 May 13;11(5):e0155645
pubmed: 27177152
J Med Chem. 2003 Mar 27;46(7):1123-6
pubmed: 12646021
Annu Rev Biochem. 1994;63:101-32
pubmed: 7979235
Science. 2007 Nov 30;318(5855):1418-23
pubmed: 17947548
Int J Impot Res. 2000 Oct;12 Suppl 4:S74-9
pubmed: 11035391
J Leukoc Biol. 2006 Oct;80(4):897-904
pubmed: 16888084
Biochem Biophys Res Commun. 2001 Mar 9;281(4):851-7
pubmed: 11237737
Mol Pharmacol. 1998 Sep;54(3):525-35
pubmed: 9730911
Biochemistry. 1995 Aug 22;34(33):10406-11
pubmed: 7544613
Nat Rev Rheumatol. 2011 Oct 25;8(1):42-54
pubmed: 22025123
Biochem Biophys Res Commun. 1999 Sep 16;263(1):251-6
pubmed: 10486285
Ann N Y Acad Sci. 2003 Jun;994:96-102
pubmed: 12851303
Photochem Photobiol. 2000 Oct;72(4):526-32
pubmed: 11045725
Pharmacol Biochem Behav. 2006 Nov;85(3):514-21
pubmed: 17113634
Cell. 1993 Mar 26;72(6):827-34
pubmed: 8458079
Anticancer Res. 2012 Apr;32(4):1245-51
pubmed: 22493355
J Mol Endocrinol. 2016 May;56(4):T77-97
pubmed: 26880796
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):79-89
pubmed: 27066320
Chem Biol. 2013 Jun 20;20(6):784-95
pubmed: 23790489
Peptides. 1990 Sep-Oct;11(5):979-82
pubmed: 2284205
Life Sci. 1996;59(10):797-801
pubmed: 8761313
Br J Dermatol. 1986 May;114(5):543-52
pubmed: 2941050
Pigment Cell Res. 2005 Dec;18(6):393-410
pubmed: 16280005
Mol Endocrinol. 2011 Jan;25(1):138-56
pubmed: 21084381
Arch Dermatol Res. 1992;284(7):424-6
pubmed: 1337693
Pigment Cell Res. 1989 Nov-Dec;2(6):478-84
pubmed: 2557603
Ann N Y Acad Sci. 2003 Jun;994:154-61
pubmed: 12851311
J Med Chem. 1999 Oct 21;42(21):4380-7
pubmed: 10543881
Biochem Pharmacol. 2001 Mar 1;61(5):613-21
pubmed: 11239505
Biochem J. 1994 Apr 15;299 ( Pt 2):367-73
pubmed: 8172596
Pigment Cell Res. 1995 Aug;8(4):202-8
pubmed: 8610071
J Mol Endocrinol. 2016 May;56(4):T135-56
pubmed: 26793988
J Cell Sci. 2002 Feb 1;115(Pt 3):455-65
pubmed: 11861753
Semin Immunol. 2022 Jan;59:101603
pubmed: 35341670
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
Biochem Biophys Res Commun. 1994 May 16;200(3):1214-20
pubmed: 8185570
Science. 2014 Nov 21;346(6212):945-9
pubmed: 25414302
Shock. 2011 Mar;35(3):308-14
pubmed: 20926985
Pigment Cell Res. 2006 Feb;19(1):76-89
pubmed: 16420249
FASEB J. 2016 Dec;30(12):4033-4041
pubmed: 27535487
Protein Eng. 1995 Jul;8(7):693-8
pubmed: 8577697
Ann N Y Acad Sci. 1999 Oct 20;885:254-61
pubmed: 10816658
Pigment Cell Melanoma Res. 2009 Dec;22(6):809-18
pubmed: 19659742
Urology. 2005 Apr;65(4):755-9
pubmed: 15833522
Peptides. 2006 Feb;27(2):413-20
pubmed: 16309786
J Invest Dermatol. 2012 Sep;132(9):2255-62
pubmed: 22572817
FASEB J. 2010 Oct;24(10):3850-60
pubmed: 20519635
Korean J Anesthesiol. 2020 Apr;73(2):151-157
pubmed: 31378052
Endocr Rev. 2006 Dec;27(7):736-49
pubmed: 17077189
Arch Biochem Biophys. 2014 Dec 1;563:4-12
pubmed: 25017567
Pigment Cell Res. 2000;13 Suppl 8:156-62
pubmed: 11041375
Pharmacol Ther. 2003 Jan;97(1):1-33
pubmed: 12493533
Ann Oncol. 2010 Oct;21 Suppl 7:vii339-44
pubmed: 20943639
Front Pharmacol. 2019 Jan 14;9:1535
pubmed: 30692924
Cell Res. 2021 Oct;31(10):1061-1071
pubmed: 34453129
J Biol Chem. 2001 Feb 23;276(8):5707-13
pubmed: 11085990
Nature. 2017 Sep 21;549(7672):399-403
pubmed: 28869973
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):313-323
pubmed: 29284608
Cell Mol Biol (Noisy-le-grand). 2006 May 30;52(2):39-46
pubmed: 16914085
Pharmacol Rev. 2004 Mar;56(1):1-29
pubmed: 15001661
Eur J Pharmacol. 2015 Dec 15;769:22-32
pubmed: 26477637
J Biol Chem. 1993 Jul 15;268(20):15174-9
pubmed: 8392067
Arch Dermatol Res. 2008 Sep;300(8):397-413
pubmed: 18690467
Hum Mol Genet. 1995 Feb;4(2):223-30
pubmed: 7757071
Endocrinology. 2003 Jan;144(1):360-70
pubmed: 12488365
Int J Dev Neurosci. 2009 Dec;27(8):857-62
pubmed: 19559780
J Invest Dermatol. 1997 Jun;108(6):838-42
pubmed: 9182807
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54
pubmed: 24790139
Nature. 1994 Oct 27;371(6500):799-802
pubmed: 7935841
Clin Dermatol. 2004 Sep-Oct;22(5):360-6
pubmed: 15556719
Circulation. 2017 Jul 4;136(1):83-97
pubmed: 28450348
Mol Neurodegener. 2022 Feb 23;17(1):16
pubmed: 35197079
Int J Cancer. 1988 Feb 15;41(2):248-55
pubmed: 2828246
Neuroscience. 2003;118(3):755-62
pubmed: 12710982
J Immunol. 1997 Apr 1;158(7):3378-84
pubmed: 9120297
J Immunol. 2015 Apr 1;194(7):3381-8
pubmed: 25725103
Photochem Photobiol Sci. 2021 Feb;20(2):315-320
pubmed: 33721252
Am J Physiol. 1999 May;276(5):R1289-94
pubmed: 10233018
J Neuroinflammation. 2019 Oct 28;16(1):192
pubmed: 31660977
J Med Chem. 1997 May 23;40(11):1738-48
pubmed: 9171884
Lancet Respir Med. 2020 Oct;8(10):963-974
pubmed: 32866440
Blood. 2006 Jan 1;107(1):60-2
pubmed: 16150949
J Neuroinflammation. 2021 Jan 19;18(1):26
pubmed: 33468172
Front Endocrinol (Lausanne). 2019 Oct 09;10:683
pubmed: 31649620
ACS Nano. 2023 May 9;17(9):8723-8733
pubmed: 37115703
Skin Health Dis. 2021 Nov 29;2(1):e78
pubmed: 35665216

Auteurs

Yoonwoo Mun (Y)

College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.

Woohyun Kim (W)

College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.

Dongyun Shin (D)

College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.
Gachon Pharmaceutical Research Institute, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH